ArticleBMC cancer2024

Correction: A real-world study of the effectiveness and safety of apatinib-based regimens in metastatic triple-negative breast cancer.

Weiwei Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.